Excedrin recalls 400k bottles of headache medicine for packaging issues, risk of poisoning

Around 433,600 bottles of Excedrin products are being recalled because some of the bottles may have a hole in the bottom.

The plastic bottles pose a poisoning risk, if there’s a hole, because a child may be able to get the caplets and swallow the painkillers.

GSK Consumer Health issued the recall for five types of Excedrin products toward the end of December 2020.

Consumers should immediately check Excedrin bottles to see if there is a hole at the bottom. If there isn’t a hole, the consumers can keep the over-the-counter medicine, according to the recall.

The recall covers 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The drugs were sold nationwide and online from March 2018 through September 2020.

The recall notice posted by the U.S. Consumer Product Safety Commission said because Excedrin contains aspirin and acetaminophen it must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).

If there is a hole, consumers should contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. You can contact GSK Consumer Relations at 800-468-7746 from 8 a.m. to 6 p.m. ET Monday through Friday, or online at Excedrin’s website and click on the “safety issue” banner at the top of the page for more information.